Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 70.42
(-0.45%)
CNY 70.42
(-0.45%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.13 Billion CNY | 10.38% |
| 2022 | 984.18 Million CNY | 22.61% |
| 2021 | 802.66 Million CNY | 59.37% |
| 2020 | 503.65 Million CNY | 26.74% |
| 2019 | 397.38 Million CNY | 27.43% |
| 2018 | 311.84 Million CNY | 17.21% |
| 2017 | 266.06 Million CNY | 4.34% |
| 2016 | 254.99 Million CNY | 26.02% |
| 2015 | 202.34 Million CNY | 5.34% |
| 2014 | 192.09 Million CNY | 1.8% |
| 2013 | 188.69 Million CNY | 1.03% |
| 2012 | 186.78 Million CNY | 9.91% |
| 2011 | 169.94 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 262.2 Million CNY | -1.52% |
| 2024 Q2 | 413.83 Million CNY | 57.83% |
| 2024 Q3 | 423.2 Million CNY | 2.26% |
| 2023 Q2 | 305.7 Million CNY | 40.43% |
| 2023 Q1 | 217.69 Million CNY | 21.28% |
| 2023 FY | 1.08 Billion CNY | 10.38% |
| 2023 Q3 | 333.76 Million CNY | 9.18% |
| 2023 Q4 | 266.24 Million CNY | -20.23% |
| 2022 FY | 984.18 Million CNY | 22.61% |
| 2022 Q2 | 237.25 Million CNY | -2.04% |
| 2022 Q1 | 242.19 Million CNY | 22.02% |
| 2022 Q4 | 179.49 Million CNY | -44.81% |
| 2022 Q3 | 325.24 Million CNY | 37.09% |
| 2021 FY | 802.66 Million CNY | 59.37% |
| 2021 Q2 | 197.29 Million CNY | 23.73% |
| 2021 Q3 | 247.43 Million CNY | 25.41% |
| 2021 Q4 | 198.48 Million CNY | -19.78% |
| 2021 Q1 | 159.45 Million CNY | -3.3% |
| 2020 Q4 | 164.9 Million CNY | -4.72% |
| 2020 Q3 | 173.06 Million CNY | 58.39% |
| 2020 FY | 503.65 Million CNY | 26.74% |
| 2020 Q2 | 109.26 Million CNY | 93.69% |
| 2020 Q1 | 56.41 Million CNY | -41.38% |
| 2019 Q4 | 96.23 Million CNY | -19.28% |
| 2019 Q2 | 99.87 Million CNY | 21.73% |
| 2019 Q1 | 82.05 Million CNY | 14.68% |
| 2019 FY | 397.38 Million CNY | 27.43% |
| 2019 Q3 | 119.22 Million CNY | 19.37% |
| 2018 Q3 | 99.98 Million CNY | 25.32% |
| 2018 FY | 311.84 Million CNY | 17.21% |
| 2018 Q4 | 71.54 Million CNY | -28.44% |
| 2018 Q2 | 79.78 Million CNY | 31.8% |
| 2018 Q1 | 60.53 Million CNY | 10.06% |
| 2017 FY | 266.06 Million CNY | 4.34% |
| 2017 Q4 | 55 Million CNY | -24.47% |
| 2017 Q2 | 70.26 Million CNY | 3.37% |
| 2017 Q1 | 67.97 Million CNY | 12.26% |
| 2017 Q3 | 72.82 Million CNY | 3.64% |
| 2016 FY | 254.99 Million CNY | 26.02% |
| 2016 Q1 | 55.26 Million CNY | 0.0% |
| 2016 Q2 | 65.83 Million CNY | 19.13% |
| 2016 Q3 | 73.34 Million CNY | 11.42% |
| 2016 Q4 | 60.55 Million CNY | -17.45% |
| 2015 FY | 202.34 Million CNY | 5.34% |
| 2014 FY | 192.09 Million CNY | 1.8% |
| 2014 Q4 | 43.14 Million CNY | 0.0% |
| 2013 FY | 188.69 Million CNY | 1.03% |
| 2012 FY | 186.78 Million CNY | 9.91% |
| 2011 FY | 169.94 Million CNY | 0.0% |